$1.95 Billion is the total value of INVESTOR AB's 8 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NDAQ | NASDAQ INC | $1,926,808,000 | +3.3% | 19,394,142 | 0.0% | 98.84% | +0.4% | |
| STIM | NEURONETICS INC | $14,910,000 | -33.6% | 1,794,228 | 0.0% | 0.76% | -35.4% | |
| AGRX | AGILE THERAPEUTICS INC | $4,177,000 | -17.9% | 3,510,189 | 0.0% | 0.21% | -20.4% | |
| HAL | New | HALLIBURTON CO | $1,197,000 | – | 63,500 | +100.0% | 0.06% | – |
| VNE | Sell | VEONEER INCORPORATED | $1,124,000 | -35.1% | 75,000 | -25.0% | 0.06% | -36.3% |
| PAR | New | PAR TECHNOLOGY CORP | $547,000 | – | 23,000 | +100.0% | 0.03% | – |
| DE | DEERE & CO | $379,000 | +1.9% | 2,245 | 0.0% | 0.02% | -5.0% | |
| VRAY | New | VIEWRAY INC | $232,000 | – | 80,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NASDAQ OMX GROUP INC | 42 | Q3 2023 | 100.0% |
| AGILE THERAPEUTICS INC | 32 | Q1 2022 | 3.5% |
| CHINACACHE INTL HLDG LTD | 21 | Q2 2018 | 7.3% |
| MATTERSIGHT CORP | 21 | Q2 2018 | 2.0% |
| CORCEPT THERAPEUTICS INC | 18 | Q3 2017 | 1.8% |
| TANGOE INC | 16 | Q1 2017 | 4.0% |
| NEURONETICS INC | 11 | Q4 2020 | 3.3% |
| CONSTANT CONTACT INC | 11 | Q4 2015 | 0.7% |
| CARLYLE GROUP LP | 11 | Q1 2018 | 0.2% |
| STANLEY BLACK & DECKER, INC. | 9 | Q3 2023 | 0.0% |
View INVESTOR AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ABB LTD | June 27, 2022 | 265,385,142 | 14.0% |
| ChinaCache International Holdings Ltd.Sold out | February 14, 2019 | 0 | 0.0% |
| AGILE THERAPEUTICS INC | February 17, 2015 | 3,510,189 | 18.9% |
| GREENWAY MEDICAL TECHNOLOGIES INCSold out | February 14, 2014 | 0 | 0.0% |
| TANGOE INC | February 14, 2014 | 1,440,000 | 3.8% |
| Mattersight CorpSold out | May 10, 2012 | 0 | 0.0% |
| ISTA PHARMACEUTICALS INC | February 14, 2011 | 1,258,075 | 3.8% |
| ACHILLION PHARMACEUTICALS INC | February 11, 2011 | 1,980,129 | 3.4% |
| ChinaCache International Holdings Ltd. | February 11, 2011 | 55,885,475 | 14.5% |
| ISTA PHARMACEUTICALS INC | April 08, 2005 | 2,001,896 | 7.8% |
View INVESTOR AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-11-06 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-14 |
| SC 13D/A | 2022-08-26 |
| 13F-HR | 2022-08-15 |
View INVESTOR AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.